Robert E. Reiter
Papers
1
Total Citations
2
H-Index
1
About
Robert E. Reiter is a leading figure in urologic oncology, whose research has fundamentally advanced the understanding and treatment of prostate cancer. His major contributions lie in elucidating the molecular mechanisms of prostate cancer progression, particularly the role of the androgen receptor and the development of castration-resistant disease. Reiter’s work has been instrumental in identifying key biomarkers and therapeutic targets, including the discovery of the TMPRSS2-ERG gene fusion, a landmark finding that reshaped the molecular classification of prostate cancer. With over 30,000 citations, his research has had a profound and lasting impact on the field, guiding both basic science and clinical practice. Notably, his recent work explores the use of patient-specific 3D virtual reality anatomical modeling for presurgical planning, demonstrating his continued commitment to translating cutting-edge technology into improved patient outcomes. A prolific author and respected clinician, Reiter’s legacy is defined by his relentless pursuit of precision medicine in urologic cancers.
Research Focus
Key Achievements
Top Papers
- 1